Using a more stringent E:T ratio of 1:10 showed uniform differences in cytotoxic activity for all CAR T cell variants across antigen expression levels, with all variants killing higher percentages of tumor cells with higher IL13Rα2 expression levels (P < 0.0001 for all comparisons; Fig. 3H). This evidence concerns the gene IL13RA2 and neoplasm.